Ke halaman utama
820К+ pasien telah mendapatkan bantuan sejak 2014
50 negara
1,500 klinik
6K+ ulasan
3K+ dokter berkualifikasi

Berapa Biaya Prosedur Diagnostik dan Perawatan Sirosis di China? Cari Tahu Sekarang

Harga diberikan berdasarkan permintaan
ChinaTurkiAustria
Transplantasi hatidari $92,000dari $45,000dari $320,000
Pengobatan sel punca untuk sirosis hatidari $19,500dari $12,000dari $40,000
Data diverifikasi oleh Bookimed per June 2026, berdasarkan permintaan pasien dan penawaran resmi dari 92 klinik di seluruh dunia. Biaya median didasarkan pada faktur nyata (2025–2026) dan diperbarui setiap bulan. Harga aktual dapat bervariasi.

Keuntungan dan Jaminan Anda bersama Bookimed

Harga Langsung

Bookimed tidak menambah biaya tambahan dalam harga perawatan Sirosis. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.

Hanya Klinik & Dokter Terverifikasi

Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Sirosis dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.

Bantuan Gratis 24/7

Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Sirosis Anda.

Mengapa kami?

Asisten pribadi Bookimed Anda

  • Mendukung Anda di setiap tahap
  • Membantu memilih klinik dan dokter yang tepat
  • Memastikan akses informasi yang cepat dan mudah

Bagikan konten ini

Video Kisah dari Pasien Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Prosedur: Pemeriksaan kesehatan wanita
Igor
It was great! Transfers, accommodation, treatment—all included.
Prosedur: Implan Gigi
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Prosedur: Pemeriksaan kesehatan wanita
Diperbarui: 05/27/2022
Ditulis oleh
Anna Leonova
Anna Leonova
Head of Content Marketing Team
Penulis medis bersertifikat dengan pengalaman 10+ tahun, membangun konten tepercaya Bookimed, didukung Master di bidang Filologi dan wawancara ahli medis di seluruh dunia.
Fahad Mawlood
Editor Medis & Data Scientist
Dokter umum. Pemenang 4 penghargaan ilmiah. Pernah bertugas di Asia Barat. Mantan Pemimpin Tim tim medis yang mendukung pasien berbahasa Arab. Kini bertanggung jawab atas pengolahan data dan akurasi konten medis.
Fahad Mawlood Linkedin
Halaman ini mungkin menampilkan informasi terkait berbagai kondisi medis, perawatan, dan layanan kesehatan yang tersedia di berbagai negara. Perhatian: konten ini hanya untuk tujuan informasi dan tidak boleh diartikan sebagai nasihat atau panduan medis. Harap konsultasikan dengan dokter atau tenaga medis profesional sebelum memulai atau mengubah perawatan medis.

FAQ tentang Pengobatan Sirosis di China

FAQ ini berasal dari pasien nyata yang mencari bantuan medis melalui Bookimed. Jawaban diberikan oleh koordinator medis berpengalaman dan perwakilan klinik terpercaya.

What are the primary treatment approaches for cirrhosis in China?

Cirrhosis treatment in China integrates standard Western medical protocols with evidence-based Traditional Chinese Medicine. Primary approaches prioritize antiviral therapy for hepatitis B and C. Facilities like Yanda International Hospital employ dual therapy. This combines Western drugs with anti-fibrotic herbs to improve liver function.

  • Etiological treatment: Long-term antivirals target viral hepatitis to slow liver damage.
  • Integrated medicine: Patent medicines like Fuzheng Huayu capsules enhance anti-fibrotic effects.
  • Complication management: Specialized care includes TIPS procedures and selective vasopressin antagonists.
  • Surgical intervention: Liver transplantation serves as definitive therapy for end-stage decompensated cases.
  • Hepatoprotective therapy: Medications like silymarin reduce persistent inflammation and promote healing.

Bookimed Expert Insight: While many countries separate traditional and modern medicine, China's Class A level III clinics standardize them. Yanda International Hospital treats 2,500,000 patients annually using this combined model. This high volume allows doctors to refine specific herbal-drug ratios. These protocols are rarely found in purely Western healthcare systems.

Patient Consensus: Patients note that traditional herbs are standard for managing chronic hepatitis symptoms. They also highlight that wait times for liver transplants are often shorter than in Western countries.

Which hospitals in China are highly recommended for liver disease and cirrhosis?

Highly recommended hospitals for liver disease and cirrhosis in China include Renji Hospital in Shanghai and West China Hospital in Chengdu. These JCI-accredited and national-level facilities specialize in advanced liver transplantation and hepatobiliary surgery. They maintain high 1-year survival rates for complex pediatric and adult cases.

  • Renji Hospital: Operates the worlds largest liver transplant center with high pediatric survival rates.
  • West China Hospital: Ranked first in mainland China for adult-to-adult living donor liver transplants.
  • Yanda International Hospital: A JCI-accredited facility in Beijing combining international protocols with traditional approaches.
  • Zhongshan Hospital: A national leader in hepatic medicine specializing in complex liver cancer treatments.
  • Fuda Cancer Hospital: Provides advanced minimally invasive therapies like cryosurgery for end-stage liver failure.

Bookimed Expert Insight: Yanda International Hospital stands out because it is a Class A level III clinic. This is the highest medical designation possible in China. While many public hospitals serve local volumes, Yanda specifically structures its 3,000 beds for international and adult patients. This focus often speeds up access for those coming from outside mainland China.

Patient Consensus: Patients emphasize that state-run facilities are best for complex transplants. Many recommend hiring a medical coordinator to handle waitlists and the significant language barriers during follow-up care.

Are stem cell transplantation therapies for cirrhosis available and effective?

Stem cell transplantation for cirrhosis is currently available in China primarily as an experimental therapy. While not a global standard, clinical trials show it is generally safe. The treatment may provide short-term improvements in liver function markers. Long-term effectiveness and complete reversal of scarring remain under investigation.

  • Treatment availability: Available mainly through clinical trials or specialized Class A level III clinics.
  • Primary cell types: Mesenchymal stem cells (MSCs) from bone marrow or umbilical cord are common.
  • Observed improvements: Research indicates temporary boosts in albumin and reduced MELD scores for 6–12 months.
  • Regulatory status: Therapies remain experimental and are not yet established as alternatives to transplantation.

Bookimed Expert Insight: Yanda International Hospital in Beijing represents a unique trend in Chinese hepatology. It holds JCI accreditation and Class A level III status. These facilities often combine international protocols with traditional approaches. While they serve 2,500,000 patients annually, stem cell procedures are typically positioned as adjunctive care rather than cures. Patients should focus on clinics with 3,000+ beds and high surgical volumes. This infrastructure suggests better management of advanced liver disease complications during experimental protocols.

Patient Consensus: Patients note that while physical fatigue sometimes decreases, follow-up imaging rarely shows structural reversal of liver scarring. Many emphasize that standard medical management like antivirals remains more reliably beneficial than stem cell injections alone.

Which specific Traditional Chinese Medicine (TCM) agents are proven to slow or reverse liver fibrosis?

Clinically proven Traditional Chinese Medicine (TCM) agents for liver fibrosis include Fuzheng Huayu capsules and Compound Biejiaruangan tablets. These formulas inhibit hepatic stellate cell activation and reduce collagen deposition. Studies show they significantly improve liver biopsy pathology and reduce serum fibrosis markers when combined with antiviral therapy.

  • Fuzheng Huayu: Combines Salvia miltiorrhiza and Cordyceps to improve liver biopsy pathology scores.
  • Compound Biejiaruangan: First CFDA-approved anti-fibrotic TCM; significantly decreases liver stiffness measurements (LSM).
  • Salvianolic acid B: Potent monomer that reduces scarring by preventing pathological blood vessel growth.
  • Anluo Huaxian: Long-term clinical data suggests improved fibrosis staging after 48 weeks of use.

Bookimed Expert Insight: Success in reversing fibrosis in China often depends on the hospital level rather than just the herbs used. Class A Level III facilities like Yanda International Hospital in Beijing serve 2,500,000 patients annually and use JCI-accredited protocols. These top-tier centers integrate TCM with over 28,500 modern technologies to monitor liver elasticity precisely while administering traditional formulas.

Patient Consensus: Patients note that combining compounds like Fufang Biejia Ruangan with strict diet changes often stabilizes fibrosis scores within 6 months. Many emphasize the need for regular imaging to track actual elasticity improvements safely.

Dapatkan konsultasi gratis

Pilih cara terbaik agar kami menghubungi Anda